Skip to content
Community, Medical Health Aged Care

Patients welcome better access to Shingrix® for immunocompromised patients

Better Access Australia and AusPIPS Inc < 1 mins read

Shingles is a painful and difficult disease, but the length and severity of the disease in immunocompromised people can often be compounded and exacerbate already complex health conditions.

AusPIP and BAA have been advocating for expanded access to Shingrix® after the 2023-24 federal budget funding decision limited access to only those “immunocompromised patients aged 18 years and over with: haemopoietic stem cell transplant; solid organ transplant; haematological malignancy; and advanced or untreated HIV.

This denied funded access to patients with common and complex immunocompromised need patients like those with primary and secondary immunodeficiency. It also denied access to patients with immune system vulnerabilities as a result of treatments for common chronic diseases such as diabetes, arthritis, chronic obstructive pulmonary disorder and multiple sclerosis without subsidised access.

From 30 August 2024 funded access to Shingrix® has been expanded to include anyone “18 years and over considered at increased risk of herpes zoster due to an underlying condition and/or immunosuppressive treatments

BAA and AusPIPs have welcomed the decision and issued the attached media release with comments from both organisations about the important first step this represents in modernising Australia's approach to adult vaccination and the important role it plays in preventative health  for adults particularly with the increasing use of treatment that impact the immune system as part of better chronic disease management.

Quotes for attribution and Quick facts attached in full press release. 


Key Facts:

This vaccine was listed on the ARTG 1950 days before it was subsidised on the National Immunisation Program 

#100days


About us:

AusPIPS Inc represents primary and secondary immunodeficient (PID SID) patients in Australia, and Better Access Australia works with patients groups to advocate for improved health, disability and social services in Australia.


Contact details:

BAA: fmcneill@betteraccessaustralia.org.au

AusPIPS president@auspips.org.au

Media

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 11/09/2024
  • 13:41
Leukaemia Foundation

The Blood Run Film – Hobart Premiere

Wednesday 25 September, 6.45pm, State Cinema, North Hobart Raising crucial funds for the Leukaemia Foundation and Australians living with blood cancer. In June 2022,…

  • Contains:
  • Medical Health Aged Care, Science
  • 11/09/2024
  • 10:55
Brandon Capital

Brandon BioCatalyst’s CUREator Incubator Boosts Preclinical and Health Security Biotech Innovations with $1.865 million in funding

MELBOURNE, Australia—Wednesday, 11 September 2024—CUREator, Australia’s national biotech incubator managed by Brandon BioCatalyst, today announced that four companies will receive top-up funding across its…

  • Contains:
  • Medical Health Aged Care
  • 11/09/2024
  • 09:52
Royal Australian College of GPs

Australia’s leading GP training college welcomes over 105 new specialist GPs in Queensland

The Royal Australian College of GPs (RACGP) has today welcomed more than 105 new fellows as specialist GPs at a fellowship ceremony in Brisbane. They shared the spotlight with four award recipients who have shown dedication to patient care in their community. Fellowship of the RACGP (FRACGP) reflects a doctor’s qualification and expertise as a specialist GP, following around 11 years of education, training, rigorous assessment, and experience in primary care. Multiple surveys show nine in 10 participants in the Australian General Practice Training program (AGPT), which is funded by the Federal Government, are satisfied with the quality of overall…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.